Meihong Lin
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, HIV/AIDS drug development and treatment, Ubiquitin and proteasome pathways, Adipose Tissue and Metabolism, Cholesterol and Lipid Metabolism
Most-Cited Works
- → Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins(2004)1,362 cited
- → SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span(2009)1,062 cited
- → Targeted Disruption of Hotair Leads to Homeotic Transformation and Gene Derepression(2013)311 cited
- → Genetic regulators of large-scale transcriptional signatures in cancer(2006)239 cited
- → Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated lncRNAs and novel transcripts(2012)85 cited
- → CSN5 Isopeptidase Activity Links COP9 Signalosome Activation to Breast Cancer Progression(2008)69 cited
- → Revealing Targeted Therapy for Human Cancer by Gene Module Maps(2008)67 cited
- → Specific Interaction of Egr1 and c/EBPβ Leads to the Transcriptional Activation of the Human Low Density Lipoprotein Receptor Gene(2003)65 cited
- → Mild Hypoxia Induces Hypertrophy of Cultured Neonatal Rat Cardiomyocytes: A Possible Endogenous Endothelin-1-mediated Mechanism(1996)63 cited
- → Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis(2004)59 cited